<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Comments on: Gilead Buys CV Therapeutics (Update 1)</title>
	<atom:link href="http://blog.pharmexec.com/2009/03/16/gilead-buys-cv-therapeuticsnow-theyve-got-heart/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmexec.com/2009/03/16/gilead-buys-cv-therapeuticsnow-theyve-got-heart/</link>
	<description>The Business of Pharmaceuticals</description>
	<lastBuildDate>Wed, 10 Mar 2010 16:21:20 -0500</lastBuildDate>
	
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Charles Stevens</title>
		<link>http://blog.pharmexec.com/2009/03/16/gilead-buys-cv-therapeuticsnow-theyve-got-heart/comment-page-1/#comment-25321</link>
		<dc:creator>Charles Stevens</dc:creator>
		<pubDate>Sat, 14 Mar 2009 22:01:00 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmexec.com/?p=713#comment-25321</guid>
		<description>You guys in your release seemed assuring that the deal to buy CVTX will be fdinalized as disclosed.  My analytical experience suggests that CVTX with its top quality drug stream is worth at least $3 more per share.  C&#039;mon guys cough it up.  Charles Stevens</description>
		<content:encoded><![CDATA[<p>You guys in your release seemed assuring that the deal to buy CVTX will be fdinalized as disclosed.  My analytical experience suggests that CVTX with its top quality drug stream is worth at least $3 more per share.  C&#8217;mon guys cough it up.  Charles Stevens</p>
]]></content:encoded>
	</item>
</channel>
</rss>
